Adverse events80

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 80

Type	Event	Organ system	Group	Affected	At risk	Events
other	Nasal congestion	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Sleep apnoea syndrome	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Tachypnoea	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Respiratory track congestion	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Rhinorrhea	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Upper respiratory tract congestion	Respiratory, thoracic and mediastinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Muscle contractions involuntary	Nervous system disorders	Onasemnogene Abeparvovec-xioi	2	22	3
other	Constipation	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	9	22	11
other	Teething	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	5	22	6
other	Diarrhoea	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	4	22	4
other	Gastroesophageal reflux disease	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	4	22	4
other	Vomiting	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	4	22	8
other	Abdominal distension	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Dysphagia	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Haematochezia	Gastrointestinal disorders	Onasemnogene Abeparvovec-xioi	2	22	2
other	Rash	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	5	22	5
other	Dermatitis atopic	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Eczema	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	3	22	3
other	Dermatitis contact	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	3
other	Dermatitis diaper	Skin and subcutaneous tissue disorders	Onasemnogene Abeparvovec-xioi	2	22	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03306277/events?page=2

API reference For AI assistants